Lido Advisors LLC Acquires 3,713 Shares of HCA Healthcare, Inc. $HCA

Lido Advisors LLC lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 45.5% during the first quarter, HoldingsChannel.com reports. The firm owned 11,872 shares of the company’s stock after purchasing an additional 3,713 shares during the period. Lido Advisors LLC’s holdings in HCA Healthcare were worth $5,619,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of HCA. Brighton Jones LLC bought a new position in shares of HCA Healthcare in the 4th quarter valued at about $1,021,000. NewEdge Advisors LLC grew its stake in HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after purchasing an additional 409 shares in the last quarter. Sivia Capital Partners LLC raised its stake in shares of HCA Healthcare by 5.5% during the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares in the last quarter. Jump Financial LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at approximately $2,073,000. Finally, Sei Investments Co. increased its holdings in HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock worth $52,328,000 after buying an additional 49,214 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA beat Q2 earnings estimates, reporting $7.59 per share versus expectations around $7.56-$7.57, while revenue rose 8.7% year over year to $20.23 billion and also topped estimates. HCA Healthcare earnings report
• Positive Sentiment: Management cited strong admissions and higher revenue per admission as key drivers of the quarter, suggesting healthy demand trends across its hospital network. Zacks article on HCA Q2 results
• Neutral Sentiment: HCA said its updated guidance is consistent with its earlier preview, so the quarter appears to confirm previously signaled results rather than deliver a major surprise. BusinessWire Q2 results
• Negative Sentiment: The company trimmed parts of its 2026 outlook, pointing to higher expenses and weaker surgical volumes as headwinds that could limit margin expansion. Zacks guidance revision article
• Negative Sentiment: Separate investor-law-firm investigations into HCA may add some legal overhang, though these notices are not operational results. Pomerantz investor alert

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Sanford C. Bernstein reissued a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Royal Bank Of Canada reduced their price target on HCA Healthcare from $534.00 to $435.00 and set an “outperform” rating for the company in a report on Wednesday, July 15th. Robert W. Baird dropped their price objective on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Stephens reduced their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Finally, JPMorgan Chase & Co. cut their price target on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a report on Tuesday, May 19th. Fourteen analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $483.45.

HCA Healthcare Trading Up 1.5%

NYSE:HCA opened at $382.28 on Friday. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The stock has a market cap of $84.80 billion, a P/E ratio of 13.15, a PEG ratio of 1.27 and a beta of 1.12. The stock has a 50 day simple moving average of $386.95 and a 200 day simple moving average of $453.73.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same period in the prior year, the company posted $6.84 earnings per share. HCA Healthcare’s revenue was up 8.7% compared to the same quarter last year. As a group, sell-side analysts forecast that HCA Healthcare, Inc. will post 29.19 EPS for the current year.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.